loading
Schlusskurs vom Vortag:
$28.17
Offen:
$27.57
24-Stunden-Volumen:
3,671
Relative Volume:
3.92
Marktkapitalisierung:
$240.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+0.00%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
Value
$27.57
$29.30
1-Wochen-Bereich:
Value
$26.00
$29.29
52-Wochen-Spanne:
Value
$26.00
$29.29

Sanuwave Health Inc Stock (SNWV) Company Profile

Name
Firmenname
Sanuwave Health Inc
Name
Telefon
770-419-7525
Name
Adresse
3360 MARTIN FARM RD, SUWANEE
Name
Mitarbeiter
31
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
SNWV's Discussions on Twitter

Vergleichen Sie SNWV mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
 icon
SNWV
Sanuwave Health Inc
29.00 34.02M 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.1874 400.55M 2.07B -1.42B -1.37B -0.6765
 icon
GOODO
Gladstone Commercial Corporation
20.82 372.90M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
2.695 113.68M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
5.20 67.38M 0 0 0 0.00
 icon
DAVEW
Dave Inc
0.1602 0 0 0 0 0.00

Sanuwave Health Inc Aktie (SNWV) Neueste Nachrichten

pulisher
Mar 08, 2025

Sanuwave Health to uplist to the Nasdaq Global Market - MSN

Mar 08, 2025
pulisher
Mar 07, 2025

AllPennyStocks.com News: Sanuwave Looking Over the Shoulder of Competitors in the Diabetic Foot Ulcer Industry - ACCESS Newswire

Mar 07, 2025
pulisher
Mar 07, 2025

Why We're Not Concerned About SANUWAVE Health, Inc.'s (NASDAQ:SNWV) Share Price - Simply Wall St

Mar 07, 2025
pulisher
Mar 07, 2025

SANUWAVE Health (NASDAQ:SNWV) shareholder returns have been splendid, earning 278% in 1 year - Yahoo Finance

Mar 07, 2025
pulisher
Mar 05, 2025

Sanuwave Health to Uplist to the Nasdaq Global Market - OrthoSpineNews

Mar 05, 2025
pulisher
Mar 04, 2025

Sanuwave Health Secures Coveted Nasdaq SpotWhat This Means for SNWV Investors - StockTitan

Mar 04, 2025
pulisher
Feb 19, 2025

Can This Regenerative Medicine Pioneer Transform the $50B Wound Care Market? Key Investor Conference Ahead - StockTitan

Feb 19, 2025
pulisher
Nov 08, 2024

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results - GlobeNewswire

Nov 08, 2024
pulisher
Nov 04, 2024

SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results - GlobeNewswire

Nov 04, 2024
pulisher
Oct 18, 2024

SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering - Yahoo Finance

Oct 18, 2024
pulisher
Oct 17, 2024

Sanuwave Health announces 1-for-375 reverse stock split - Yahoo Finance

Oct 17, 2024
pulisher
Oct 16, 2024

SANUWAVE Health Announces 1-For-375 Reverse Stock Split - StockTitan

Oct 16, 2024
pulisher
May 10, 2024

SANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial Results - The Globe and Mail

May 10, 2024
pulisher
Apr 01, 2024

SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer - GlobeNewswire

Apr 01, 2024
pulisher
Aug 28, 2023

Eden Prairie-based Sanuwave Health seeks Nasdaq listing in SPAC deal - Star Tribune

Aug 28, 2023
pulisher
Aug 24, 2023

SANUWAVE signs merger agreement with SEPA - Medical Device Network

Aug 24, 2023
pulisher
Aug 23, 2023

SANUWAVE Health, Inc., a Leading Provider of FDA Approved - GlobeNewswire

Aug 23, 2023
pulisher
May 31, 2023

Sanuwave appoints new CEO - Mass Device

May 31, 2023
pulisher
May 24, 2023

SANUWAVE Health, Inc. Appoints Morgan Frank as Chief Executive Officer - GlobeNewswire

May 24, 2023
pulisher
Oct 20, 2021

SANUWAVE Health to Host Conference Call and Provide Business Update - The Globe and Mail

Oct 20, 2021
pulisher
Jun 11, 2020

Sanuwave announces intent to acquire Celularity’s UltraMist - Mass Device

Jun 11, 2020
pulisher
May 19, 2020

Sanuwave partners with The Mobile Health Company - Mass Device

May 19, 2020
pulisher
Jun 08, 2017

Sanuwave Health inks dev deal with eKare for wound care integration - Mass Device

Jun 08, 2017
pulisher
Aug 15, 2016

Sanuwave files for de novo FDA nod for DermaPace wound care device - Mass Device

Aug 15, 2016
pulisher
Mar 24, 2016

Sanuwave trial misses efficacy endpoint but shows superiority at 24 weeks - Mass Device

Mar 24, 2016

Finanzdaten der Sanuwave Health Inc-Aktie (SNWV)

Es liegen keine Finanzdaten für Sanuwave Health Inc (SNWV) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_devices ZBH
$106.95
price down icon 0.57%
medical_devices STE
$224.20
price up icon 0.83%
medical_devices PHG
$26.66
price up icon 2.16%
$69.35
price up icon 1.09%
$81.21
price down icon 0.75%
medical_devices EW
$68.70
price up icon 0.94%
Kapitalisierung:     |  Volumen (24h):